Calmark receives order from Switzerland

Calmark receives order from Switzerland

Press releases
Calmark Sweden AB (publ) announces today that the Company has received an order from the distributor in Switzerland, LabForce AG, covering the Calmark Neo platform and bilirubin tests. The economic value of today's order is of minor importance, but it is important from a launch perspective.

As previously disclosed, an exclusive distributor agreement has been signed with the company LabForce regarding marketing and sales of the Calmark POC system in Switzerland.

“I am happy for the order which shows that LabForce has started active sales work towards their customers, the clinics,” says Magdalena Tharaldsen, Director International Business Development at Calmark. “LabForce distributes more than 40 different brands in its home market and has a very good reputation. I look forward to deepening our cooperation.”

This information is information that Calmark Sweden AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, on 7 October 2021, 12:10 CET.

Every care has been taken in the translation of this document. In the event of discrepancies, the Swedish original will supersede the English translation.